Real-world study affirms benefits of dupilumab in pediatric patients with uncontrolled atopic dermatitisMay 18, 2023Atopic Dermatitis
Crisaborole induces normalization of mild-to-moderate atopic dermatitis proteomeMay 18, 2023Atopic Dermatitis
Tralokinumab effective against moderate-to-severe atopic dermatitis in adolescentsMay 18, 2023Atopic Dermatitis
Upadacitinib shows a favorable benefit-risk profile in adolescents with moderate-to-severe atopic dermatitisMay 18, 2023Atopic Dermatitis
Dermatology NewsThe antimicrobial peptide that even Pharma can loveMay 18, 2023Mixed TopicsInfectious DiseasesWounds
Dermatology NewsExpunging ‘penicillin allergy’: Your questions answeredMay 18, 2023DermatopathologyAtopic Dermatitis
Dermatology NewsBrepocitinib shows promise for psoriatic arthritis patientsMay 17, 2023Psoriatic Arthritis
Dermatology NewsDocs fervently hope federal ban on noncompete clauses goes throughMay 17, 2023Business of Medicine
Dermatology NewsTeledermatology follow-up after Mohs surgery gets a thumbs up from patientsMay 17, 2023Dermatologic SurgeryNonmelanoma Skin CancerBusiness of MedicineMelanoma
Persistent Wounds Refractory to Broad-Spectrum AntibioticsMay 17, 2023WoundsAcneDiversity in Medicine
